MedTech
Why Robinhood?
You can watch MedTech and buy or sell other stocks, ETFs, and their options commission-free!About MTAC
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
MTAC Key Statistics
Stock Snapshot
With a market cap of 259.17M, MedTech(MTAC) trades at $4.22. The stock has a price-to-earnings ratio of -2.99.
On 2026-07-25, MedTech(MTAC) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 201.49K.
The stock's 52-week range extends from a low of $2.20 to a high of $7.95.
The stock's 52-week range extends from a low of $2.20 to a high of $7.95.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.